eStudySite   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: San Diego CA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (4)

Key: eStudySite (0) Acquired (4)

bictegravir (Biktarvy) (1 trial)

doravirine (pifeltro) (1 trial)

emtricitabine (emtriva) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

Drugs in Phase 2 Trials (2)

Key: eStudySite (0) Acquired (2)

alpha-lipoic acid (1 trial)

yk-fh312 (1 trial)

Drugs in Phase 1 Trials (2)

Key: eStudySite (0) Acquired (2)

mva (1 trial)

scy-635 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 5
  • # of Trial APIs: 8